Scholarlink

<p>The rising burden of endocrine and metabolic diseases demands scalable and accessible screening tools. Here we developed Reti-Pioneer, a multitask retinal imaging framework that integrates quality-aware modules with pre-trained foundation models for efficient, multidisease detection. In general, the framework was developed using 107,730 color fundus photographs from both community-based and hospital-based cohorts and achieved area under the receiver operating characteristic curve values on internal test data of 0.833 (95% confidence interval 0.810–0.856) for type 2 diabetes mellitus, 0.832 (0.799–0.866) for gout, 0.787 (0.742–0.833) for osteoporosis, 0.740 (0.726–0.755) for hypertension, 0.736 (0.721–0.751) for hyperlipidemia and 0.699 (0.667–0.730) for thyroid disease. The framework generalized well to six external cohorts from both resource-limited and high-resource settings, and showed biological interpretability via plasma proteomic correlations. In a primary care silent trial, it completed screening in 30.6 ± 6.0 s per case, notably faster than standard laboratory workflows. A subsequent clinical pilot for type 2 diabetes mellitus yielded an area under the receiver operating characteristic curve of 0.776 (0.710–0.842) and negative predictive value of 0.966 (0.946–0.983), surpassing the Finnish Diabetes Risk Score, with high acceptance from clinicians and patients. Overall, Reti-Pioneer could provide a translatable, low-cost pathway from oculomics to actionable clinical screening.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

AI framework for multidisease detection via retinal imaging

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月28日

查看全文
  • Xiayin Zhang,
  • Qinyi Li,
  • Yinhao Liang,
  • Chunran Lai,
  • Jiahui Cao,
  • Yangqin Feng,
  • Wenyi Hu,
  • Hongyang Jiang,
  • Chunxin Liu,
  • Feng Zhang,
  • Shan Wang,
  • Ying Fang,
  • Cuomu Duojie,
  • Lumei Hu,
  • Fan Xu,
  • Kaiyi Chi,
  • Miao Lin,
  • Li Li,
  • Yih Chung Tham,
  • Yukun Zhou,
  • Carol Y. Cheung,
  • Xiaohong Yang,
  • Bin Sheng,
  • Zhuoting Zhu,
  • Ching-Yu Cheng,
  • Wing W. Y. Ng,
  • Honghua Yu

摘要

The rising burden of endocrine and metabolic diseases demands scalable and accessible screening tools. Here we developed Reti-Pioneer, a multitask retinal imaging framework that integrates quality-aware modules with pre-trained foundation models for efficient, multidisease detection. In general, the framework was developed using 107,730 color fundus photographs from both community-based and hospital-based cohorts and achieved area under the receiver operating characteristic curve values on internal test data of 0.833 (95% confidence interval 0.810–0.856) for type 2 diabetes mellitus, 0.832 (0.799–0.866) for gout, 0.787 (0.742–0.833) for osteoporosis, 0.740 (0.726–0.755) for hypertension, 0.736 (0.721–0.751) for hyperlipidemia and 0.699 (0.667–0.730) for thyroid disease. The framework generalized well to six external cohorts from both resource-limited and high-resource settings, and showed biological interpretability via plasma proteomic correlations. In a primary care silent trial, it completed screening in 30.6 ± 6.0 s per case, notably faster than standard laboratory workflows. A subsequent clinical pilot for type 2 diabetes mellitus yielded an area under the receiver operating characteristic curve of 0.776 (0.710–0.842) and negative predictive value of 0.966 (0.946–0.983), surpassing the Finnish Diabetes Risk Score, with high acceptance from clinicians and patients. Overall, Reti-Pioneer could provide a translatable, low-cost pathway from oculomics to actionable clinical screening.